Justice Department Closes Investigation into AstraZeneca’s Clinical Trial

Drug Industry Daily
A A
The Department of Justice has closed its civil investigation into alleged data falsification in a clinical trial for AstraZeneca’s heart drug Brilinta, a move that clears the way for the drug to potentially reach blockbuster status.

To View This Article:

Login

Subscribe To Drug Industry Daily